FDA animal and veterinary recalls
Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injecti… recalled by Hospira
Listed for 9 days 1 change recorded
In plain words
On 22 May 2024, Hospira recalled Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units. US FDA gives the reason as: Device & Drug Safety – Potential Packaging Defect
If you have this product, stop feeding it and keep the packaging and the receipt. If your pet is unwell, call your vet. This page is what US FDA published and when it changed; it is not advice.
What to keep if a recall turns into money back · Search every recall we hold · Follow Hospira as a feed
What changed
Added to FDA animal and veterinary recalls
Current values
- Announced
- 2024-05-22
- Announced display
- 05/22/2024
- Brand
- Hospira
- Company
- Hospira Inc.
- Product
- Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units
- Reason
- Device & Drug Safety – Potential Packaging Defect
Version 1, captured 2026-09-02 10:43:30 UTC. sha256 fb5045a6d430972a437acff6947aef3dd360db774e7f1fc96870a6fc749263fc